CRISPR And CRISPR-Associated (Cas) Genes Sales Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And…

New Jersey, United States,- Latest update on CRISPR And CRISPR-Associated (Cas) Genes Sales Market Analysis report published with extensive market research, CRISPR And CRISPR-Associated (Cas) Genes Sales Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the CRISPR And CRISPR-Associated (Cas) Genes Sales industry. With the classified CRISPR And CRISPR-Associated (Cas) Genes Sales market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the CRISPR And CRISPR-Associated (Cas) Genes Sales market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the CRISPR And CRISPR-Associated (Cas) Genes Sales market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the CRISPR And CRISPR-Associated (Cas) Genes Sales Market growth opportunities in the industry.

CRISPR And CRISPR-Associated (Cas) Genes Sales Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including CRISPR And CRISPR-Associated (Cas) Genes Sales market size, volume and value, as well as price data.

CRISPR And CRISPR-Associated (Cas) Genes Sales Market competition by top Manufacturers:

CRISPR And CRISPR-Associated (Cas) Genes Sales Market Classification by Types:

CRISPR And CRISPR-Associated (Cas) Genes Sales Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the CRISPR And CRISPR-Associated (Cas) Genes Sales Market Report:

Cataloging the competitive terrain of the CRISPR And CRISPR-Associated (Cas) Genes Sales market:

Unveiling the geographical penetration of the CRISPR And CRISPR-Associated (Cas) Genes Sales market:

The report of the CRISPR And CRISPR-Associated (Cas) Genes Sales market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the CRISPR And CRISPR-Associated (Cas) Genes Sales Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into CRISPR And CRISPR-Associated (Cas) Genes Sales Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Continued here:

CRISPR And CRISPR-Associated (Cas) Genes Sales Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And...

Fate Therapeutics Announces FDA Clearance of IND Application for First-ever iPSC-derived CAR T-Cell Therapy | DNA RNA and Cells | News Channels -…

DetailsCategory: DNA RNA and CellsPublished on Monday, 13 July 2020 10:45Hits: 484

FT819 CAR T-cell Product Candidate Derived from Clonal Master iPSC Line with Novel CD19-specific 1XX CAR Integrated into TRAC Locus

Phase 1 Clinical Study will Evaluate FT819 for Patients with Advanced B-cell Leukemias and Lymphomas

SAN DIEGO, CA, USA I July 09, 2020 I Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Companys Investigational New Drug (IND) application for FT819, an off-the-shelf allogeneic chimeric antigen receptor (CAR) T-cell therapy targeting CD19+ malignancies. FT819 is the first-ever CAR T-cell therapy derived from a clonal master induced pluripotent stem cell (iPSC) line, and is engineered with several first-of-kind features designed to improve the safety and efficacy of CAR T-cell therapy. The Company plans to initiateclinical investigation of FT819for the treatment of patients with relapsed / refractory B-cell malignancies, including chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), and non-Hodgkin lymphoma (NHL).

The clearance of our IND application for FT819 is a ground-breaking milestone in the field of cell-based cancer immunotherapy. Our unique ability to produce CAR T cells from a clonal master engineered iPSC line creates a pathway for more patients to gain timely access to therapies with curative potential, said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. Four years ago, we first set out under our partnership with Memorial Sloan Kettering led by Dr. Michel Sadelain to improve on the revolutionary success of patient-derived CAR T-cell therapy and bring an off-the-shelf paradigm to patients, and we are very excited to advance FT819 into clinical development.

FT819 was designed to specifically address several limitations associated with the current generation of patient- and donor-derived CAR T-cell therapies. Under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, M.D., Ph.D., Director, Center for Cell Engineering, and Head, Gene Expression and Gene Transfer Laboratory at MSK, the Company incorporated several first-of-kind features into FT819 including:

The multi-center Phase 1 clinical trial of FT819 is designed to determine the maximum tolerated dose of FT819 and assess its safety and clinical activity in up to 297 adult patients across three types of B-cell malignancies (CLL, ALL, and NHL). Each indication will enroll independently and evaluate three dose-escalating treatment regimens: Regimen A as a single dose of FT819; Regimen B as a single dose of FT819 with IL-2 cytokine support; and Regimen C as three fractionated doses of FT819. For each indication and regimen, dose-expansion cohorts of up to 15 patients may be enrolled to further evaluate the clinical activity of FT819.

At the American Association for Cancer Research (AACR) Virtual 2020 Meeting, the Company presented preclinical data demonstrating FT819 is comprised of CD8 T cells with uniform 1XX CAR expression and complete elimination of endogenous TCR expression. Additionally, data from functional assessments showed FT819 has antigen-specific cytolytic activity in vitro against CD19-expressing leukemia and lymphoma cell lines that is comparable to that of healthy donor-derived CAR T cells, and persists and maintains tumor clearance in the bone marrow in an in vivo disseminated xenograft model of lymphoblastic leukemia.

Fate Therapeutics has an exclusive license for all human therapeutic use to U.S. Patent No. 10,370,452 pursuant to its license agreement with MSK1, which patent covers compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell including an iPSC. In addition to the patent rights licensed from MSK, the Company owns an extensive intellectual property portfolio that broadly covers compositions and methods for the genome editing of iPSCs using CRISPR and other nucleases, including the use of CRISPR to insert a CAR in the TRAC locus for endogenous transcriptional control.

1 Fate Therapeutics haslicensedintellectual propertyfrom MSK on which Dr. Sadelain is aninventor.As a result of the licensing arrangement, MSK has financial interests related to Fate Therapeutics.

About Fate Therapeutics iPSC Product PlatformThe Companys proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments. Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. The Companys first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment. As a result, the Companys platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. Fate Therapeutics iPSC product platform is supported by an intellectual property portfolio of over 300 issued patents and 150 pending patent applications.

About Fate Therapeutics, Inc.Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Companys immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). The Companys immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit http://www.fatetherapeutics.com.

SOURCE: Fate Therapeutics

Go here to read the rest:

Fate Therapeutics Announces FDA Clearance of IND Application for First-ever iPSC-derived CAR T-Cell Therapy | DNA RNA and Cells | News Channels -...

Magnetic Resonance Imaging (MRI) Market Applications, Future Trends, Size Value, Growth Statistics, Sales Projection and COVID-19 Impact Analysis By…

(MENAFN - iCrowdNewsWire) Jul 13, 2020

Magnetic Resonance Imaging (MRI) Market Size, Growth and Share Analysis By Field Strength (High-Field MRI Systems), Type (Close MRI and Open MRI), Disease Application (Brain and Neurological MRI), Regional Outlook and End-Users Forecast to 2023

Magnetic Resonance Imaging (MRI) Market Overview

The magnetic resonate particles are the radio waves that provides the three-dimensional images of the internal organs and joints in the body. MRI shows you the detailed structure of the organ without any invasive surgery. It also detects the heart, surrounding view of the artery and the troubles related to it. MRI study also involves Brain MRI, individual organ MRI and the extremities. The MRI market works on four demands. The Global Magnetic Resonance Imaging (MRI) Market size is anticipated to reach USD 5 billion at a CAGR of 3.5% by the end of 2023, says Market Research Future (MRFR). MRI is a non-invasive diagnostic technology that produces digital images of the internal body structures. It uses the magnetic resonate atoms to show the pictures of the inner body tissue and organs.

The four applications of magnetic resonance imaging market include the non-invasive procedure in practices, the harmful effects of the radiation-based imaging, rising in the research and development of the life science and the increasing use of magnetic resonance imaging in the drug discovery.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6194

There are certain other factors also that fuel the growth of the MRI market. The primary factor that is increasing the demand for MRI is the increase in the geriatric population. The increase in the geriatric population leads to the rise of cardiovascular, neurological and ophthalmic disorders which results in the growth of the MRI market. However, certain factors affect the growth of magnetic resonance imaging market such as high cost of the instruments, strict regulatory, insufficient reimbursement policies and the lack of skilled operators.

Magnetic Resonance Imaging (MRI) Market Segmentation

The global magnetic resonance imaging market is segmented into four types.

Based on the magnetic field strength, the magnetic resonance imaging market is divided into four types

Based on the architectural model, the MRI market is of two kinds;

based on its application, the global magnetic resonance imaging market is classified into four types. The segmentation includes

The MRI market is also segmented based on end-users that include

As of now, the medium and the high-field segments are having large scale adoption. Usually, the medium and high-field sections produce better image quality to the end-users that helps in better treatment of the disease. The increasing demand for MRI in the hospitals and clinics is rising with the highest MRI market share. The MRI market is one of the significant markets for investment.

Magnetic Resonance Imaging (MRI) Market Regional Outlook

Magnetic Resonance Imaging Market Competitive Landscape:

The global magnetic resonance imaging (MRI) market is getting boosted by the strategic decisions of several companies like Siemens AG, Hitachi, GE Healthcare, Canon Medical Systems, Toshiba Corporation, Philips, Xingaoyi, Toshiba Corporation, and Aurora Imaging Technologies, Inc. These companies are planning mergers, acquisitions, collaborations, and others to ensure their own stand in the market. Their growing investment in the research and development sector is promoting healthy competition, which could ensure a better growth rate in the coming years.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/magnetic-resonance-imaging-market-6194

Magnetic Resonance Imaging (MRI) Market News

Browse More Healthcare Research Reports at:

Structural Heart Devices Market: Type (Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems), Indication (Valvular Heart Disease, Cardiomyopathy), Procedure (Replacement Procedures, Repair Procedures)Global Forecast Till 2023

https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385

mHealth Market Information, By Therapeutics(respiratory, mental and neurological disorders, fitness & lifestyle) By Application(monitoring, diagnosis & treatment, wellness & prevention) - Forecast to 2022

https://www.marketresearchfuture.com/reports/mobile-health-market-1816

Gene Editing Market Research Report, By Methods (Crispr, Talen, Zfn, Antisense Technology And Others), By Applications (Plant Genetic Engineering, Animal Genetic Engineering, Gene Therapy, Microorganisms Genetic Engineering), By End User (Biotechnology, Pharmaceutical, Contract Research Organization) Global Forecast Till 2023

https://www.marketresearchfuture.com/reports/gene-editing-market-707

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Read more:

Magnetic Resonance Imaging (MRI) Market Applications, Future Trends, Size Value, Growth Statistics, Sales Projection and COVID-19 Impact Analysis By...

RNA and DNA Extraction Kit Market Revenue, Challenges And Forecast 2028 – Owned

Global RNA and DNA Extraction Kit Market: Overview

RNA and DNA extraction plays a crucial role in cancer genetic studies, which involves mutation analysis, comparative genomic hybridization, and microsatellite analysis. The rising incidences of cancer globally are creating a need for the advanced RNA and DNA extraction kit and are expected to drive market growth in the coming years.

Based on the product, the market is expected to segregate into RNA extraction kit and DNA extraction kit. Of these, the DNA extraction kit segment is expected to account for the leading share in the overall RNA and DNA extraction kit market. Additionally, the applications of DNA extraction kits mainly in the genetic engineering of animals and plants in pharmaceutical manufacturing. This is expected to fuel growth of RNA and DNA extraction kit market.

Get Sample Copy of the Report @https://www.tmrresearch.com/sample/sample?flag=B&rep_id=5600

Global RNA and DNA Extraction Kit Market: Notable Developments

Some of the key players in the global RNA and DNA extraction kit market include Agilent Technologies Inc., Merck KGaA, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., and QIAGEN. Introduction of new products is benefiting growth of the global RNA and DNA extraction kit market.

Global RNA and DNA Extraction Kit Market: Drivers and Restraints

The rise and progress in customized drug have helped social insurance experts create exact sub-atomic focused on treatment dependent on a persons hereditary cosmetics and prescient information explicit to patients. The advancement of customized medication requires genome-mapping investigations of separated cells, which can be completed with the assistance of DNA and RNA extraction kits. DNA extraction kits are utilized to recognize quality polymorphisms identified with sickness or medication digestion though RNA extraction kits are utilized to break down RNA combination in separated cells. With the expanding appropriation of customized prescription, the demand for RNA and DNA extraction kits will likewise develop.

There is a developing rate of malignant growth over the globe. The inside and out understanding of tumor hereditary qualities given by trend-setting innovations in malignant growth research has empowered the advancement of novel treatments to battle disease-causing qualities. The virtue, amount, and nature of separated RNA assume a huge job in the accomplishment of RNA examination and examination and consequent capacity of specific quality articulation. RNA extraction likewise helps in recognizing circulating tumor cells (CTCs) and non-intrusive observing of cutting edge malignant growths.

Request TOC of the Report @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=5600

Global RNA and DNA Extraction Kit Market: Regional Outlook

On the basis of region, the RNA and DNA extraction kit market is segmented into North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. Of these, North America is expected to dominate the global RNA and DNA extraction kit market owing to robust innovation procedures running in the region. This factor is expected to offer robust growth opportunities to key players in RNA and DNA extraction kit market. Additionally, increasing demand for the automated systems coupled with the rising need for the RNA and DNA extraction kit across the extraction kits especially in the medical diagnosis is expected to drive growth of the market in coming years.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,3739 Balboa St # 1097,San Francisco, CA 94121United StatesTel: +1-415-520-1050

Excerpt from:

RNA and DNA Extraction Kit Market Revenue, Challenges And Forecast 2028 - Owned

Bioengineered Protein Drugs Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026…

New Jersey, United States,- Latest update on Bioengineered Protein Drugs Market Analysis report published with extensive market research, Bioengineered Protein Drugs Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Bioengineered Protein Drugs industry. With the classified Bioengineered Protein Drugs market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Bioengineered Protein Drugs market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Bioengineered Protein Drugs market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Bioengineered Protein Drugs Market growth opportunities in the industry.

Bioengineered Protein Drugs Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Bioengineered Protein Drugs market size, volume and value, as well as price data.

Bioengineered Protein Drugs Market competition by top Manufacturers:

Bioengineered Protein Drugs Market Classification by Types:

Bioengineered Protein Drugs Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Bioengineered Protein Drugs Market Report:

Cataloging the competitive terrain of the Bioengineered Protein Drugs market:

Unveiling the geographical penetration of the Bioengineered Protein Drugs market:

The report of the Bioengineered Protein Drugs market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Bioengineered Protein Drugs Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Bioengineered Protein Drugs Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

See more here:

Bioengineered Protein Drugs Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026...

CRISPR And CRISPR-Associated (Cas) Genes Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And…

New Jersey, United States,- Latest update on CRISPR And CRISPR-Associated (Cas) Genes Market Analysis report published with extensive market research, CRISPR And CRISPR-Associated (Cas) Genes Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the CRISPR And CRISPR-Associated (Cas) Genes industry. With the classified CRISPR And CRISPR-Associated (Cas) Genes market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the CRISPR And CRISPR-Associated (Cas) Genes market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the CRISPR And CRISPR-Associated (Cas) Genes market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the CRISPR And CRISPR-Associated (Cas) Genes Market growth opportunities in the industry.

CRISPR And CRISPR-Associated (Cas) Genes Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including CRISPR And CRISPR-Associated (Cas) Genes market size, volume and value, as well as price data.

CRISPR And CRISPR-Associated (Cas) Genes Market competition by top Manufacturers:

CRISPR And CRISPR-Associated (Cas) Genes Market Classification by Types:

CRISPR And CRISPR-Associated (Cas) Genes Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the CRISPR And CRISPR-Associated (Cas) Genes Market Report:

Cataloging the competitive terrain of the CRISPR And CRISPR-Associated (Cas) Genes market:

Unveiling the geographical penetration of the CRISPR And CRISPR-Associated (Cas) Genes market:

The report of the CRISPR And CRISPR-Associated (Cas) Genes market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the CRISPR And CRISPR-Associated (Cas) Genes Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into CRISPR And CRISPR-Associated (Cas) Genes Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Read the original:

CRISPR And CRISPR-Associated (Cas) Genes Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And...

COVID-19 Impact ON Food Security Technology Market : Which trend will emerge in near future? – Owned

The globalFood Security Technology Marketis carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Food Security Technology market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Food Security Technology market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Food Security Technology market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global Food Security Technology market.

Leading players of the global Food Security Technology market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Food Security Technology market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Food Security Technology market. It also provides useful recommendations for new as well as established players of the global Food Security Technology market.

Request sample copy of this report:https://www.reporthive.com/request_sample/2321923

Major Players:

BASFCargillKraft FoodsNestleMahindra and MahindraNovozymesBayer

Segmentation by Product:

No-till techniqueGenetic engineeringBio seedsMicro irrigationOther

Segmentation by Application:

GovermentPrivate

Regions and Countries:U.S, Canada, France, Germany, UK, Italy, Rest of Europe, India, China, Japan, Singapore, South Korea, Australia, Rest of APAC, Brazil, Mexico, Argentina, Rest of LATAM, Saudi Arabia, South Africa, UAE.

Report Objectives

Table of Contents

Report Overview:It includes major players of the global Food Security Technology market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Food Security Technology market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Food Security Technology market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Food Security Technology market by application, it gives a study on the consumption in the global Food Security Technology market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Food Security Technology market are profiled in this section. The analysts have provided information about their recent developments in the global Food Security Technology market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Food Security Technology market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Food Security Technology market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Food Security Technology market.

Key Findings:This section gives a quick look at important findings of the research study.

Request for Customization:https://www.reporthive.com/request_customization/2321923

About us:

Our research base consists of a wide spectrum of premium market research reports. Apart from comprehensive syndicated research reports, our in-house team of research analysts leverages excellent research capabilities to deliver highly customized tailor-made reports. The market entry strategies presented in our reports has helped organizations of all sizes to generate profits by making timely business decisions. The research information including market size, sales, revenue, and competitive analysis offered, is the product of our excellence in the market research domain.

Read more:

COVID-19 Impact ON Food Security Technology Market : Which trend will emerge in near future? - Owned

Trending: CRISPR Genome Editing Market 2020-2026: Key Vendor Landscape By Regional Output, Demand By Countries And Future Growth|Global CRISPR Genome…

Los Angeles, United State The report titled Global CRISPR Genome Editing Market Research Report 2020 is one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global CRISPR Genome Editing market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global CRISPR Genome Editing market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global CRISPR Genome Editing market is carefully analyzed and researched about by the market analysts.

Global CRISPR Genome Editing Market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2019 to 2025.

Top Key Players of the Global CRISPR Genome Editing Market: Editas Medicine, CRISPR Therapeutics, Horizon Discovery, Sigma-Aldrich, Genscript, Sangamo Biosciences, Lonza Group, Integrated DNA Technologies, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Caribou Biosciences, Precision Biosciences, Cellectis, Intellia Therapeutics

Download Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart): https://www.qyresearch.com/sample-form/form/1495487/global-crispr-genome-editing-market

The Essential Content Covered in the Global CRISPR Genome Editing Market Report:

* Top Key Company Profiles.

* Main Business and Rival Information

* SWOT Analysis and PESTEL Analysis

* Production, Sales, Revenue, Price and Gross Margin

* Market Share and Size

Global CRISPR Genome Editing Market Segmentation By Product:

Genetic EngineeringGene LibraryHuman Stem CellsOthers

Global CRISPR Genome Editing Market Segmentation By Application:

Biotechnology CompaniesPharmaceutical CompaniesOthers

In terms of region, this research report covers almost all the major regions across the globe such as North America, Europe, South America, the Middle East, and Africa and the Asia Pacific. Europe and North America regions are anticipated to show an upward growth in the years to come. While CRISPR Genome Editing Market in Asia Pacific regions is likely to show remarkable growth during the forecasted period. Cutting edge technology and innovations are the most important traits of the North America region and thats the reason most of the time the US dominates the global markets. CRISPR Genome Editing Market in South, America region is also expected to grow in near future.

Key questions answered in the report

* What will be the market size in terms of value and volume in the next five years?

* Which segment is currently leading the market?

* In which region will the market find its highest growth?

* Which players will take the lead in the market?

* What are the key drivers and restraints of the markets growth?

Get Customized Report in your Inbox within 24 hours @https://www.qyresearch.com/customize-request/form/1495487/global-crispr-genome-editing-market

Research Methodology

* Data triangulation and market breakdown

* Research assumptions Research data including primary and secondary data

* Primary data includes breakdown of primaries and key industry insights

* Secondary data includes key data from secondary sources

We provide detailed product mapping and analysis of various market scenarios. Our analysts are experts in providing in-depth analysis and breakdown of the business of key market leaders. We keep a close eye on recent developments and follow latest company news related to different players operating in the global CRISPR Genome Editing market. This helps us to deeply analyze companies as well as the competitive landscape. Our vendor landscape analysis offers a complete study that will help you to stay on top of the competition.

About Us:

We established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

See the article here:

Trending: CRISPR Genome Editing Market 2020-2026: Key Vendor Landscape By Regional Output, Demand By Countries And Future Growth|Global CRISPR Genome...

Bioengineered Protein Drugs Sales Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To…

New Jersey, United States,- Latest update on Bioengineered Protein Drugs Sales Market Analysis report published with extensive market research, Bioengineered Protein Drugs Sales Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Bioengineered Protein Drugs Sales industry. With the classified Bioengineered Protein Drugs Sales market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Bioengineered Protein Drugs Sales market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Bioengineered Protein Drugs Sales market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Bioengineered Protein Drugs Sales Market growth opportunities in the industry.

Bioengineered Protein Drugs Sales Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Bioengineered Protein Drugs Sales market size, volume and value, as well as price data.

Bioengineered Protein Drugs Sales Market competition by top Manufacturers:

Bioengineered Protein Drugs Sales Market Classification by Types:

Bioengineered Protein Drugs Sales Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Bioengineered Protein Drugs Sales Market Report:

Cataloging the competitive terrain of the Bioengineered Protein Drugs Sales market:

Unveiling the geographical penetration of the Bioengineered Protein Drugs Sales market:

The report of the Bioengineered Protein Drugs Sales market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Bioengineered Protein Drugs Sales Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Bioengineered Protein Drugs Sales Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

View original post here:

Bioengineered Protein Drugs Sales Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To...

Plant Breeding and CRISPR Plant Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To…

New Jersey, United States,- Latest update on Plant Breeding and CRISPR Plant Market Analysis report published with extensive market research, Plant Breeding and CRISPR Plant Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Plant Breeding and CRISPR Plant industry. With the classified Plant Breeding and CRISPR Plant market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Plant Breeding and CRISPR Plant market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Plant Breeding and CRISPR Plant market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Plant Breeding and CRISPR Plant Market growth opportunities in the industry.

Plant Breeding and CRISPR Plant Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Plant Breeding and CRISPR Plant market size, volume and value, as well as price data.

Plant Breeding and CRISPR Plant Market competition by top Manufacturers:

Plant Breeding and CRISPR Plant Market Classification by Types:

Plant Breeding and CRISPR Plant Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Plant Breeding and CRISPR Plant Market Report:

Cataloging the competitive terrain of the Plant Breeding and CRISPR Plant market:

Unveiling the geographical penetration of the Plant Breeding and CRISPR Plant market:

The report of the Plant Breeding and CRISPR Plant market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Plant Breeding and CRISPR Plant Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Plant Breeding and CRISPR Plant Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Follow this link:

Plant Breeding and CRISPR Plant Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To...

Pseudorabies Virus Vaccine Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 -…

New Jersey, United States,- Latest update on Pseudorabies Virus Vaccine Market Analysis report published with extensive market research, Pseudorabies Virus Vaccine Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Pseudorabies Virus Vaccine industry. With the classified Pseudorabies Virus Vaccine market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Pseudorabies Virus Vaccine market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Pseudorabies Virus Vaccine market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Pseudorabies Virus Vaccine Market growth opportunities in the industry.

Pseudorabies Virus Vaccine Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Pseudorabies Virus Vaccine market size, volume and value, as well as price data.

Pseudorabies Virus Vaccine Market competition by top Manufacturers:

Pseudorabies Virus Vaccine Market Classification by Types:

Pseudorabies Virus Vaccine Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Pseudorabies Virus Vaccine Market Report:

Cataloging the competitive terrain of the Pseudorabies Virus Vaccine market:

Unveiling the geographical penetration of the Pseudorabies Virus Vaccine market:

The report of the Pseudorabies Virus Vaccine market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Pseudorabies Virus Vaccine Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Pseudorabies Virus Vaccine Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

More here:

Pseudorabies Virus Vaccine Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 -...

LA’s ‘Wet Markets’ Could Be On The Chopping Block – LAist

A cashier at L.A. Fresh Poultry weighs some chicken. (Chava Sanchez/LAist)

Our news is free on LAist. To make sure you get our coverage: Sign up for our daily newsletters. To support our non-profit public service journalism: Donate Now.

Zoila Isabel Sandoval sits on a hard, wooden chair in front of the spice rack at L.A. Fresh Poultry, waiting to place her order with a clerk. The basket of her rolling walker is piled with groceries. She's in a good mood. Today is her son's 40th birthday and they're going to celebrate with a big family lunch. She plans to make several Guatemalan-style dishes, including arroz con pollo chapina and pollo en jocon, a tomatillo-based stew. To do that, she needs six freshly slaughtered chickens.

Sandoval grew up in the farm town of San Rafael Las Flores in southern Guatemala, where she and her mother raised chickens and pigs at home.

"I liked seeing them grow, especially when they had little chicks or piglets," Sandoval says in Spanish.

After moving to Los Angeles two decades ago, she struggled to find a place where she could buy freshly slaughtered chickens.

"I have been eating like this ever since I was in my mother's womb," she says with a laugh.

When she discovered L.A. Fresh Poultry, a 2,000-square-foot market not far from her MacArthur Park apartment, she felt a sense of relief.

The store sells live chickens, turkeys, quails, ducks, squabs and rabbits, which its butchers will slaughter on site. In the eyes of the law, this will probably make L.A. Fresh Poultry a "wet market" a business that may soon be forbidden in the city of Los Angeles.

On June 10, the Los Angeles City Council passed a motion that could signal the beginning of the end for wet markets. The motion asks the L.A. Department of City Planning, the Department of Building and Safety and the City Attorney's office to come up with "a precise definition" of "wet market" and provide recommendations about which "establishments and practices should be prohibited."

Bob Blumenfield, one of the two city councilmembers who sponsored the motion, told us the information he's requesting is not an outright wet market ban yet. Rather, it's a "report on the feasibility of such an ordinance." But, he added, "It's the first step to prohibit the sale of living creatures for human consumption in the city of Los Angeles."

Although city officials haven't provided a definition for "wet market," the state of California defines "live animal market," an equivalent term, as "a retail food market where, in the regular course of business, animals are stored alive and sold to consumers for the purpose of human consumption." A further explanation, spelled out in California Penal Code PEN 597.3, says, "'Animal' means frogs, turtles, and birds sold for the purpose of human consumption, with the exception of poultry."

L.A. city officials are still in the process of working with L.A. City Attorney Mike Feuer to write the ordinance, according to Councilmember Paul Koretz, the motion's other sponsor. "The focus is primarily on animals that have unknown implications in terms of diseases they could spread," Koretz told us, although he acknowledges there is no guarantee the ordinance would be limited to animals that are commonly tied to illnesses.

Although no wet market or butcher shop has been the source of a COVID-19 outbreak in L.A., "There may be hygienic questions in terms of how they operate, and questions of animal cruelty in terms of how [animals] are kept and slaughtered," Koretz said. He told us he has no firsthand experience shopping at wet markets in L.A.

Ren Rowland, the chairwoman of animal rights organization PawPAC, supports the motion. She told us that whether wet market animals are wild (think bullfrogs or turtles) or domestic (think chickens, ducks, rabbits), "They also endure these terrible experiences of being transported and trafficked in these different containers in cages, in trucks and planes."

"We don't advocate for any markets to close for business," Rowland said. "We just believe that we need to stop the practice of the on-site slaughter."

The city of L.A., which has approximately 4 million residents, has maybe two dozen stores that slaughter and sell animals on their premises, according to a list provided by Blumenfield's staff. Blumenfield says the list isn't exhaustive and could potentially include businesses that are not wet markets. Regardless, these businesses make up a tiny fraction of L.A.'s nearly 1,200 markets and grocery stores.

Koretz told us he doesn't know of any major food-borne illness outbreaks that began at L.A. wet markets, "but there are some people that have become sick from eating some of the more exotic foods." He added that his knowledge of cruelty issues is secondhand.

So why the motion that could put an end to wet markets? And why do it now? One word: coronavirus.

"The fact that this virus potentially started in a wet market [in China] caused us to look at ourselves in Los Angeles, and do we have these kinds of wet markets that are cruel and potentially dangerous," Blumenfield said.

No one has conclusively determined the origins of COVID-19. Many scientists believe it originated in nature in one animal species (possibly bats) then jumped to another species (such as pangolins) before wreaking havoc on humans. In one theory, that transfer happened in a seafood and animal market near Wuhan, China.

The phrase "wet market" can mean a lot of things. Most of them merely sell fresh meat, fish and other perishable food. Others, like the one near Wuhan, also sell wild animals such as bats and civets. Although scientists may never be able to pinpoint the virus's origin, that hasn't stopped politicians or conspiracy theorists or racists from making "wet market" a pejorative term and blaming people or cultures commonly associated with them for the coronavirus pandemic.

President Donald Trump has repeatedly used the term "Chinese virus" to describe the COVID-19. As hate crimes against Asian Americans continue to rise, White House press secretary Kayleigh McEnany recently defended Trump's use of the term "kung flu," saying, "It's not a discussion about Asian Americans, who the president values and prizes as citizens of this great country. It is an indictment of China for letting this virus get here."

At the start of 2020, most Americans had never heard of wet markets. A few months later, they were Public Health Enemy #1. Even Canadian Lite Rocker Bryan Adams got in on the action.

By April, the Asian Pacific Policy & Planning Council's Hate Tracker had received more than 1,400 reports of verbal abuse, assault and shunning directed at Asian Americans, or people who look Asian.

Racism triggered by the so-called wet market-coronavirus connection even trickled down to the business sector. In late January, as the coronavirus became a growing global concern, Chinese restaurants started to see a major slump in customers.

The L.A. City Council's motion to ban wet markets which only applies within the city's boundaries and not in the San Gabriel Valley, where there are about a dozen such markets won't only impact Asian Americans. It will impact Muslims, Latinos, Armenians and anyone else who prefers meat from freshly slaughtered animals.

Koretz says he understands how the motion could be seen as discriminatory, but he views that interpretation as the result of a top-down leadership problem. "My only discomfort is with President Trump unnecessarily trying to utilize the hate against anybody different," he said, adding that Trump's divisive and racist language is an "unfortunate side element to this issue."

But Koretz maintains that there's a valid reason for the motion: "We're seeing how devastating this particular virus can be. And this practice, even though it is culturally associated with certain communities, the potential diseases will not be associated with any community. This is targeted towards health."

To Zoila Sandoval, the idea of buying meat that has been slaughtered elsewhere then frozen, swathed in plastic and shipped from hundreds of miles away is hard to accept.

Two times a week since L.A. Fresh Poultry opened 14 years ago, she has made the 20-minute walk from her home on Vermont Avenue to the store. The chance to buy freshly slaughtered animals is precisely why she comes here.

"It's killed here," she says. "It's not frozen and stored for I don't know how long. It's fresh and healthier."

She's not alone. Outside of wet markets, there's plenty of demand for freshly slaughtered, non-factory-farmed, humanely killed animals, whether it's the organic steaks of Belcampo Meat Co. or the organic, air-chilled thighs of Mary's Free-Range Chicken. Never mind the urban hipsters who home-raise chickens, sometimes for food.

Aside from a giant fiberglass rooster (and his small rabbit companion) perched on the roof, L.A. Fresh Poultry is an unassuming store next to the Virgil Avenue on-ramp of the 101. Behind the counter, bills from different countries have been stuck to the wall around a sign that reads, "I love Egypt."

Painted on another wall outside the store, a colorful parade of creatures including Daffy Duck and Bugs Bunny beckons potential customers. "Why buy frozen when you can buy fresh?" reads the mural. Indeed, in addition to the foodstuffs that any such store carries, L.A. Fresh Poultry has a live animal storage room, where chickens, rabbits and quails are kept in cages.

The market has been a neighborhood staple since opening in 2006. It serves customers seven days a week, from 8:30 a.m. until 6 p.m. This is owner Abdel Salam Elhawary's second such store. The first, Al Salam Pollera in East L.A., opened nearly 40 years ago, and is still thriving. He says approximately 80% to 85% of his customers are Mexican immigrants and the rest originally come from Guatemala or El Salvador. Elhawary also has a third store, Van Nuys Live & Fresh Poultry, which he opened in 2012.

A 68-year-old Egyptian immigrant who once taught French in his home country, Elhawary came to Los Angeles in 1980 and worked in a bank for nearly a decade before getting into the grocery game.

He started his business so Muslims could have more access to halal meats. For meat to be certified halal, whoever is doing the slaughtering must follow certain rules. The animal can't be unconscious. The butcher needs to use an extremely sharp instrument to prevent snags and the prolonging of any suffering. Allah's name must be said during the slaughter. Then, the animal must be hung upside down so the blood can drain. (By way of comparison, in industrial slaughterhouses, chickens might be shackled then electrocuted to death while sheep and pigs might be gassed into unconsciousness before they're slaughtered.)

"We have a Muslim community," Elhawary says, "it's about 40,000 to 50,000 Muslims around the [Koreatown] area. Mostly, the Bangladesh people come, and the Middle Eastern and others."

Hollywood resident Haji Ceesay, 53, is one of the market's many customers. Ceesay, a Muslim who comes from The Gambia, moved to Los Angeles in 1991. Ceesay prefers to consume freshly slaughtered animals for religious and cultural reasons.

"Back home that's what we do," Ceesay says. "We buy live chicken and it's different than the frozen ones here."

Ceesay left the store that day with six chickens.

These days, Elhawary says Muslims make up about 40% of his customers. He says the rest of his clients are Angelenos who originally came from Mexico, Central America, Armenia or Korea. He's as surprised as anyone by the diversity of his clientele, but he's happy to have the customers.

After 40 years in business, Elhawary isn't upset about the provision in the ordinance that would require him to stop selling live birds, such as quail and squab. Demand is low. The provision that would require him to stop slaughtering is another matter.

If that goes into effect, "I am gonna die," Elhawary says. "All my life is doing this. It's not only my shop. It's all over. Millions of people love to eat the fresh one."

"Millions" may be a bit of an exaggeration, but it's undeniable that live animal markets fill a need for thousands of residents, most of whom, by almost any account, are immigrants and/or people of color.

Sam Sammars, an L.A. Fresh Poultry customer who lives in East L.A., says he discovered the market in 2014 and has been coming once or twice a week since then. For him, it's worth the trip. The meat here is fresher than store-bought factory meat, and the prices are good $15 to $16 for a large, freshly slaughtered chicken.

"It tastes so natural, as if you're in the farm," he said while waiting in line to place his order.

Sammars grew up on a farm in Columbus, Ohio, where there weren't many supermarkets in the area, so he got used to the taste of fresh everything fresh fruits, fresh vegetables and fresh meat. Now 35, he says conventional farming and meat production, with their pesticides, genetic engineering, hormones and antibiotics, produce food that isn't as nutritious.

He said that if markets are prohibited from selling live and freshly slaughtered animals without the law making any distinction between chickens and ducks vs. frogs, exotic birds and wild animals, "It would be very strongly devastating."

At typical grocery stores and supermarkets, most meat comes from livestock that has been raised on "factory farms" (or what the USDA calls Concentrated Animal Feeding Operations), then slaughtered at industrial slaughterhouses and transported to markets by refrigerated trucks.

"Wet markets are selling a live animal or slaughtering it in front of you. That's very different," Blumenfield says. "When animals are just brought in and killed for human consumption, it completely avoids the regulatory system."

In fact, the state of California regulates how live animal markets, custom slaughterhouses and retail poultry plants can operate. The facilities are inspected by the California Department of Food and Agriculture to make sure they abide by health and safety regulations, which are designed to prevent the inhumane treatment of animals and the spread of diseases. The L.A. County Department of Public Health, for its part, regulates the retail portion of such businesses in accordance with the California Retail Food Code.

Regardless of the oversight process, Blumenfield also points out that the motion stems from a "cruelty issue."

"The idea is: Can we stop this cruel practice in Los Angeles?" he says, referring to slaughtering of rabbits, frogs and birds on site. "A wet market is the opposite of what you would find in a humane society."

Chef Wes Avila doesn't see wet markets that way. He says he used to buy 50 to 80 chickens per week from wet markets in Chinatown when he launched Guerrilla Tacos as a food truck, in 2014.To Avila, the complaints about wet markets aren't about ethics, they're about aesthetics. They just make some people uncomfortable.

"People want to pretend that meat comes from some magic pig tree or chicken tree. That's not the way it happens. It has to come from somewhere."

According to Elhawary, the chickens at his markets come from farms in Fresno or Ramona and he makes sure all the animals he sells are healthy.

"When they have bruises from the transportation, we trim it and throw the bad parts away. We use sharp knives, and we do the chicken fast and accurately. We don't let the chicken suffer," Elhawary says.

Nevertheless, activists who support the closure of wet markets prioritize another concern the transportation process. Rowland, of PawPAC, says people who want to maximize their profits will transport as many live animals as possible in trucks or planes, which is dangerous and inhumane.

Rowland says she doesn't believe slaughtering animals in industrial slaughterhouses then transporting the meat to grocery stores is necessarily more humane, safer or healthier.

But, she says, "There are no factory farms in the city of Los Angeles and so because of that, we don't have to address that issue."

The proposal to ban wet markets in L.A. is one part of Rowland's larger goal: putting a stop to any activities that cause animals suffering or torture. She says she's starting with California but wants that message to sweep the world.

Councilman Koretz, for his part, is waiting on the report so he can decide "whether it's a practical thing to pursue."

Although the report was supposed to come out by July 10 30 days after the motion was passed it has not yet been completed. A staffer at Councilman Koretz's office said the city expects to see the report in late July or early August.

If officials want to move forward with the proposal, the City Council will have to pass another motion directing City Attorney Feuer to draft the law.

While officials wait for the city's feasibility report, Elhawary worries. If the proposed measure moves forward, he says he may organize a demonstration with his customers. He fears that if he has to stop selling freshly slaughtered poultry, his three markets will go out of business.

In the meantime, Zoila Sandoval has been watching as the workers at L.A. Fresh Poultry process her order. After she's requested her six chickens at the counter, two licensed butchers grab them from the cages that are not visible to customers. They take the birds to the killing room, where they're slaughtered, drained and plucked. Then, two more workers remove the giblets, wash the chickens and pass them through an open doorway to a clerk.

One of the shop's two butchers, Merare Nataneal, has spent 12 years honing his craft. At 66, he worries the ordinance, if passed, will put him on the unemployment line.

"This is my work, and I don't want to lose it," Nataneal says in Spanish. "It's an uncomfortable position knowing that they might want to close this type of business down."

Behind the counter, a clerk weighs, wraps and bags the freshly killed birds. After paying at the register, Sandoval leaves L.A. Fresh Poultry under the gaze of Foghorn Leghorn, six still-warm birds piled in the basket of her walker as she rolls down Virgil Ave, heading home to make lunch for her son.

Here is the original post:

LA's 'Wet Markets' Could Be On The Chopping Block - LAist

Yeast Market Trend, CAGR Status, Growth, Analysis and Forecast to 2028 – 3rd Watch News

Brewing or beer making represents a massive and highly lucrative sector. According to a study, global alcohol consumption has constantly been on the rise, and the consumption of beer accounts for the highest volume share. Yeast, being the cardinal ingredient used in the production of beer, provides the right proportion of texture and flavor to beer during its production. As a result, increasing demand and consumption of beer has been elevating the globalyeast market, which is anticipated to grow at a CAGR of 5.4% during the forecast period 2018-2026. The market valuation has been estimated to be over US$ 10,200 Mn by 2026 end.

Yeast Innovation: The Future of Brewery

The brewing industry has overcome a slew of challenges and moved beyond times when technological breakthroughs were not applied to the beer crafting process. According to a research, one small, low-capital innovation, within the reach of all beer makers is enhancing and improvising the yeast they use in their beer. Even though yeast is partially responsible for imparting the flavor and aroma to beer, brewers often compare yeast to hops. This leaves yeasts dynamic nature untapped, which can be used for product enhancements.

Get Sample Copy Of This Report @https://www.persistencemarketresearch.com/samples/23347

Research has shown that non-GMO development techniques such as selective breeding can be used to optimize the brewing strains. Ultimately, brewers can enhance the quality of beer by innovative yeast that can be fully customized pertaining to the brewery and its beer with the specific desired parameters in fermentation performance, processing, storage, flavor, and aroma, without compromising quality or brand identity.

Alternatives to Traditional Straining to Drive Innovation in Yeast Market

Studies on the beer and yeast market have pointed at various possibilities that would drive the use of yeast in beer making. For instance, to develop brewers yeast, market players could use hop-accentuating enzymes in high volume which will change the aroma and flavor profiles of the different hop varieties used in beer. Additionally, brewers can add a trait to increase fermentation temperature ranges which would produce desired flavor profiles at lower temperatures, eliminating the problem of off odors that occur at higher temperatures.

Request For Methodology @https://www.persistencemarketresearch.com/methodology/23347

Genetically Engineered Yeast to Offer Excellent Taste to Beer

From great-tasting to cloudy and off-taste beers, yeast accounts for up to a third of a brews final flavor. Brewing yeast has its own genetic limitations. For researchers across the globe, brewing yeast is at the forefront of genetic research and synthetic biology, which is pushing the boundaries of genetic engineering. Geneticists can now tweak the genetic code of brewing yeast to suppress or express certain beer characteristics. From taking out the gene responsible for the butter-flavored molecule diacetyl to using specific gene for banana and clove flavors made by hefeweizen yeast brewers would now be able to use this ability of genetically modified (GM) yeast for the production of beer.

Whether it is straining of yeast or making use of genetically engineered yeast, increased consumption of alcoholic beverages in the world, with beer leading the consumption segment, has witnessed several yeast innovations in recent years, favoring the market growth. For more insights, speak to our expert food analysts at Persistence Market Research to know more about the yeasts market and its impact on the end-user industry.

Read the original here:

Yeast Market Trend, CAGR Status, Growth, Analysis and Forecast to 2028 - 3rd Watch News

Nanoparticles Used to Deliver Gene Therapy for Macular Degeneration – AZoNano

Written by AZoNanoJul 8 2020

Two researchers from Johns Hopkins Universityan ophthalmologist and an engineerhave successfully used nanoparticles to deliver gene therapy for blinding eye disease. They achieved this by performing experiments in mice and rats.

Image Credit: Johns Hopkins Medicine.

Using an exclusively designed large molecule, the researchers could compact huge bundles of therapeutic DNA to be delivered into the cells of the eye.

Reported in the Science Advances journal on July 3rd, 2020, the study offers evidence of the prospective value of nanoparticle-delivered gene therapy for the treatment of wet age-related macular degeneration.

Macular degeneration is an eye disease in which blood vessel growth is abnormal, causing damage to the light-sensitive tissue at the back of the eye, together with rarer, inherited blinding diseases of the retina.

Several gene therapy techniques rely on viral vectors, which tap the natural ability of a virus to carry genetic material into cells. But viruses tend to create an immune response that prevents repeat dosing, and the one most often used for ocular gene therapy is not capable of carrying large genes.

Some of the most prevalent inherited retinal degenerations are due to mutations in large genes that simply cannot fit into the most commonly used viral vector.

Peter Campochiaro, MD, Eccles Professor of Ophthalmology, Johns Hopkins University School of Medicine

Campochiaro is also a member of the Johns Hopkins Medicine Wilmer Eye Institute.

Campochiaro and Jordan Green, PhD, created a new technique to overcome such drawbacks, which involves using a biodegradable polymer that surrounds and compacts long DNA stretches. This helps create nanoparticles with the potential to enterthe cells. This technology enables the conversion of the cells of the eye into mini factories for a therapeutic protein.

The researchers first tested whether the nanoparticles enter their target cells by loading the nanoparticles with a gene for a fluorescent protein that makes cells glow similar to a glow stick.

Using the glowing molecule, the researchers were able to find the location, duration, and amount of gene expression that can be achieved using the nanoparticles.

Even eight months following treatment, it was found that most of the light-sensitive cells in the eyes of the rats glowed, demonstrating that the nanoparticles effectively loaded the fluorescent gene into the cells.

A similar experiment was also performed using the nanoparticles to shuttle a biologically relevant gene into the eye. A gene for vascular endothelial growth factor (VEGF) was loaded into the nanoparticles, where the gene takes part in the growth of abnormal blood vessels in people suffering from wet macular degeneration.

The eyes of 30 rats were injected with the nanoparticles that carried the VEGF gene, and the effects in the retina were determined one, two, and five months post-injection. One month post-injection, abnormal blood vessels developed in each tested rat under and inside the retina, similar to those seen in patients suffering from wet macular degeneration.

The abnormal blood vessels were found to be more widespread at two and five months post-injection, and there was related scarring under the retina such as those observed in chronic untreated wet macular degeneration.

These results show that the genes delivered by nanoparticles stayed active within the cells for several months.

Peter Campochiaro, MD, Eccles Professor of Ophthalmology, School of Medicine, Johns Hopkins University

Lastly, the researchers tested the ability of a nanoparticle to deliver a therapeutic gene for the disease by using mice that had been genetically engineered to develop a kind of wet macular degeneration such as those seen in humans. Nanoparticles were loaded with a gene that synthesizes a protein that neutralizes VEGF.

At present, such proteins that block VEGF proteins are injected by physicians into the eyes of people suffering from macular degeneration. This treatment helps control the overgrowth of abnormal, leaky blood vessels. However, this process must be repeated often and is cumbersome for patients and their caretakers.

Three weeks post-injection of nanoparticles with the gene for the anti-VEGF protein, a 60% decrease in abnormal blood vessels was observed in the mice.

The same effect was observed 35 days later.

These results are extremely promising. We have the ability to reach the cells most significantly affected by degenerative eye disease with nonviral treatments that can allow the eye to create its own sustained therapies.

Jordan Green, PhD, Professor of Biomedical Engineering, School of Medicine, Johns Hopkins University

In the United States, approximately 1.6 million people suffering from macular degeneration are administered injected drugs to the eye every four to six weeks. A gene therapy treatment could offer a means for the tissue of the eye to prevent further deterioration of vision with only a few initial treatments.

Genetic diseases that lead to blindness could be similarly treated by introducing functional versions of genes disabled by inherited mutations.

Jikui Shen, Jayoung Kim, Stephany Tzeng, Kun Ding, Zibran Hafiz, Da Long, and Jiangxia Wang from the Johns Hopkins University School of Medicine are the other researchers involved in this study.

This study was financially supported by the National Eye Institute (01EY031097, R21EY026148, R01EY028996, EY01765), the National Institute of Biomedical Imaging and Bioengineering (R01EB022148) Research to Prevent Blindness (the Dr H. James and Carole Free Catalyst Award and an unrestricted grant), the Louis B. Thalheimer Fund for Translational Research; the Barth Syndrome Foundation, Samsung, Conrad and Lois Aschenbach, Per Bang-Jensen, Andrew and Yvette Marriott, and Jean Lake.

Shen, J., et al. (2020) Suprachoroidal gene transfer with nonviral nanoparticles. Science Advances. doi.org/10.1126/sciadv.aba1606.

Source: https://www.hopkinsmedicine.org/

See the rest here:

Nanoparticles Used to Deliver Gene Therapy for Macular Degeneration - AZoNano

Nema To Draft Biosafety Regulations And Guidelines – New Vision

The National Environment Management Authority (NEMA) plans to draft regulations that will guide the environmental release of genetically modified organisms.

Kasese district chairman leading a team that visited Mubuku GM cassava trial garden. PHOTOS: Prossy Nandudu

The National Environment Management Authority (NEMA) plans to draft regulations that will guide the environmental release of genetically modified organisms.

Under the revised Act of 2019, NEMA was given the mandate to regulate GMOs in the environment although the regulations were not made, until the Genetic Engineering Regulatory Act (GERA) that is before parliament is passed into law to give details on the regulatory process.

This was revealed by the executive director NEMA, Dr.Tom Okurut during a meeting organised by the Science Foundation for Livelihoods and Development (SCIFODE) at a monthly media bio cafe, on NEMA Act 2019 emerging regulations and guidelines on Wednesday.

"In the absence of a specific law for GMO regulation, we should move to draft regulations and guidelines, we didn't want to go first, now that it has stayed, we cannot delay, we must start because GMOs are already with us," said Okurut.

To ensure that the process takes shape, Okurut said they're in talks stakeholders such as the Ministry of Science Technology and Innovations (MOSTI), Uganda National Council for Science and Technology (UNCST), researchers among others to secure funding for the process.

According to Okurut, the NEMA Act 1995 had omissions especially on aspects such as oil and gas industry waste, electronic waste, and management of GMOs.

He, however, adds that these have since been catered for in the amended act of 2019, apart from the aspect of GMOs that we are supposed to make laws that will regulate it. But for NEMA to make the regulations, they had to wait for the GERA bill to be passed into law, an issue which is not yielding results.

"There are still pseudo scientists peddling lies about the technology without taking time to understand the basic science used by researchers in developing these products and we need the law to regulate the use, entry, consumption of all products from GMOs," Okurut said.

Okurut was backed by the director of regulation and biosafety at the Ministry of Science Technology and Innovations, Dr.James Kasigwa who seconded NEMA to use the amended act and regulate GMOs.

"Since we don't have a dedicated law, we can make use of NEMA act to have a stop-gap, issues of GMOs are real. Kenya now plants genetically modified cotton, they are about to release cassava and our borders are porous, what is in Kenya, will find its way into Uganda. Let us leverage any provisions in NEMA to have anything workable to put in place a regulatory framework," added Kasigwa.

Dr. Kasigwa noted that MOSTI is willing to cooperate with NEMA to ensure that a regulatory framework is in place

Currently, the agriculture sector is faced with the challenge of pests and diseases and climate change which are threatening many crops like bananas devastated by the bacterial wilt, Maize production suffers from drought-related insect pests among others.

"Fortunately many of these have been addressed through biotechnology and are in research fields waiting for regulation to be availed to the farming community to improve our productivity and competitiveness," added Isaac Ongu, the executive director of Scifode.

Follow this link:

Nema To Draft Biosafety Regulations And Guidelines - New Vision

PM Imran orders distribution of wheat from government warehouses – The Express Tribune

ISLAMABAD:

Prime Minister Imran Khan on Friday ordered distribution of wheat from government warehouses in Punjab to the local markets to mitigate the effects of an impending flour crisis.

The bureaucracy had advised the premier to distribute wheat stocks from government warehouses in October.

However, the premier said, You should immediately bring wheat to the market and provide it at a cheaper price by setting up markets and sale points.

The premier added that if need be, wheat would be imported in October if needed.

Earlier, on Jun 9 it was reported that Pakistan is facing a shortfall of 1.4 million tons of wheat because of a decrease in yield, a development that is set to aggravate the existing flour crisis in the coming months.

The Federal Committee on Agriculture (FCA) was informed about the impending crisis during a meeting held on Wednesday, June 9, to review the Khareef season.

The wheat production target last year was set at 27 million tonnes. This year, there is a shortfall of 1.4 million tonnes and 79.95pc of the procurement target has been achieved.

Speaking during the meeting, Federal National Food Security and Research Minister Syed Fakhar Imam stressed the need to increase wheat production.

We need a breakthrough in high-yield wheat variety through genetic engineering, he added.

Our country has the best irrigation system which is not being used properly. Wheat is grown on 36pc of the countrys cultivated area.

Food Security Commissioner Dr Waseem informed the participants of the meeting that after many years, the country had exceeded the chickpea production target of 540,000 tonnes.

This year, there will be saving of Rs87 million as there will be less chickpea import, he added.

Potato production for the current year is 4.43 million tonnes against 4.4 million tonnes recorded last year. Balochistan also recorded a bumper crop of tomato this year.

Imam said there was a need to increase the production of oil seeds (sunflower, canola, rosehip and mustard).

The Indus River System Authority representative informed the participants of the meeting that there would 9pc more water available for Khareef season this year.

Go here to read the rest:

PM Imran orders distribution of wheat from government warehouses - The Express Tribune

Molecular Probes Market 2020 Global Industry Analysis, Opportunities, Major Applications and Forecast to 2027 – Cole of Duty

Molecular probes are the part of small RNA or DNA which recognizes the complementary sequences in DNA and RNA molecules. Molecular probes are used in identification and isolation of specific RNA or DNA sequences from organism. Molecular probes offers as the resources for various applications such as chromosomal mapping, molecular cytogenetics, and DNA fingerprinting. Also, molecular probes are used in various fields such as physiology, embryology, scientific classification, and hereditary building.

Increase in development of map-based cloning of agronomical important genes, marker based gene tags, phylogenetic analysis is expected to boost the global molecular probes market growth. Furthermore, continuous development in genetic engineering technology will have the positive impact on global molecular probes market growth. Molecular probes are developed and designed for genetic engineering research and widely used for diagnosis of infectious diseases. Moreover, increase in government initiatives for clinical investigations in molecular probes, it is expected to propel the growth of molecular probes market during this forecast period.

Get Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Molecular-Probes-Market/request-sample

However, lack of robust reimbursement framework for customized and genomic medicine is the major restraining factor which is expected to hinder the growth of global molecular probes market.

Market Key Players

Various key players are discussed in this report such as BioRad Laboratories, Hologic, Sysmex Corporation,Dako, Danaher, Thermo Fisher Scientific, and bioMerieux SA.

Market Taxonomy

By Product

By Application

By End User

By Region

Get discount on this report @ https://qualiketresearch.com/request-sample/Molecular-Probes-Market/ask-for-discount

About Us

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

Contact Person:

Vishal Thakur

Research Support Specialist

QualiKet Research

6060 N Central Expy #500, TX 75204, U.S.A

Email: [emailprotected]

Website: https://qualiketresearch.com

Read this article:

Molecular Probes Market 2020 Global Industry Analysis, Opportunities, Major Applications and Forecast to 2027 - Cole of Duty

Chitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Releas | IJN – Dove Medical Press

Amir Hashemi,1 Masoumeh Ezati,2 Javad Mohammadnejad,3 Behzad Houshmand,4 Shahab Faghihi5

1Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran; 2Tissue Engineering and Biomaterials Research Center, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran 14965/161, Iran; 3Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran; 4Department of Periodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran; 5Tissue Engineering and Biomaterials Research Center, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran 14965/161, Iran

Correspondence: Javad Mohammadnejad; Shahab Faghihi Tel +9821 8609-3078Tel/ Fax +98 21 44787386Fax +98(21)88497324Email mohamadnejad@ut.ac.ir; sfaghihi@nigeb.ac.ir

Background: Ineffective integration has been recognized as one of the major causes of early orthopedic failure of titanium-based implants. One strategy to address this problem is to develop modified titanium surfaces that promote osteoblast differentiation. This study explored titanium surfaces modified with TiO2 nanotubes (TiO2 NTs) capable of localized drug delivery into bone and enhanced osteoblast cell differentiation.Materials and Methods: Briefly, TiO2 NTs were subjected to anodic oxidation and loaded with Metformin, a widely used diabetes drug. To create surfaces with sustainable drug-eluting characteristics, TiO2 NTs were spin coated with a thin layer of chitosan. The surfaces were characterized via scanning electron microscopy, atomic force microscopy, and contact angle measurements. The surfaces were then exposed to mesenchymal bone marrow stem cells (MSCs) to evaluate cell adhesion, growth, differentiation, and morphology on the modified surfaces.Results: A noticeable increase in drug release time (3 days vs 20 days) and a decrease in burst release characteristics (85% to 7%) was observed in coated samples as compared to uncoated samples, respectively. Chitosan-coated TiO2 NTs exhibited a considerable enhancement in cell adhesion, proliferation, and genetic expression of type I collagen, and alkaline phosphatase activity as compared to uncoated TiO2 NTs.Conclusion: TiO2 NT surfaces with a chitosan coating are capable of delivering Metformin to a bone site over a sustained period of time with the potential to enhance MSCs cell attachment, proliferation, and differentiation.

Keywords: titania nanotubes, titanium, osteogenic differentiation, anodization, mesenchymal bone marrow stem cells, MSCs

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Excerpt from:

Chitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Releas | IJN - Dove Medical Press

Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ – CNBC

As businesses and schools seek to reopen, most public health experts agree that Covid-19 testing is needed more than ever.

The team behind Ginkgo Bioworks, a genetic engineering start-up, is going all in.

Using equipment from Illumina, a maker of DNA sequencing machines, the company which made CNBC's 2020 Disruptor 50 list is working on technology to run a half million tests per day, said Jason Kelly, Ginkgo's co-founder and CEO.The technology, if approved by federal regulators, will be saliva-based, which in theory would make it easier for consumers to get tested than using the nasal swabs most tests employ today.

"We didn't initially have enough tests, but now we've ramped up to about 400,000 per day," he said. "That's enough for our clinical diagnostics needs. ... However, we are now entering phase 2 of this thing."

Ginkgo, a darling of the burgeoning synthetic biology sector, got its start in 2009 when a group of MIT scientists got together to develop biotechnology tools for industries including agriculture, pharmaceuticals and cosmetics. In essence, it develops custom microorganisms that aim to replace technology with biology. Think of it as a way to program cells, a bit like you'd program computers.

"We program DNA and cells to make them do new things," said Kelly, who describes the company as the largest designers of "printing DNA" in the world.

The Boston-based company has raised close to $1 billion to date, as investors clamor to throw money into companies at the intersection of health care and technology. Kelly maintains that enthusiasm is warranted. The cost of sequencing DNA data is coming down faster than the cost of processing data on computers,outpacingMoore's law.

As Kelly puts it, "the chips aren't getting that much faster," but in biology things are "exponentially improving."

Right now Kelly believes Ginkgo can best apply its technology to help ramp up coronavirus testing in the U.S.

As the CEO explained, the initial crop of tests were primarily used to determine if people experiencing Covid-19 symptoms did, in fact, have the virus. But now, as people are going back to their lives, there will be an increasing need for regular testing of people who don't have symptoms.

For instance, Amazon plans to test its fulfillment center workers every two weeks, as well as monitor outbreaks in the community.

That means the country is going to need a lot more coronavirus tests.

Ginkgo started surveyingthe various techniques to scale up testing back in the spring, including antigen (a technology that looks for viral surface proteins), CRISPR-based (a genome editing technique) and next-generation sequencing approaches. Companies have only recently been granted emergency-use authorizations from the U.S. Food and Drug Administration for these types of tests. All of them, if ramped up, could theoretically augment the polymerase chain reaction tests that are currently the gold standard for Covid-19.

Ginkgo has decided to focus on next-generation sequencing with Illumina, which has already been granted an emergency-use approvalfor its Covid-19 test that is designed to sequence the full genome of the virus.

"Beyond diagnostic testing, Illumina and a number of our customers are exploring NGS-based workflows to enable high-volume screening to support a return to work and school," Illumina CEO Francis deSouza said in a statement.

In May Ginkgo announced it had raised another $70 million, including from Illumina, to fund its expansion in the diagnostics field. It is also using the money tobuild out its own testing facility in its highly automated Boston Seaport labs.

More from Disruptor 50:Moderna CEO sees success with Covid-19 vaccineThe technology that will dominate daily life on the other side of coronavirusCLEAR poised to lead in biometric screening for Covid

Kelly can't predict exactly when the company will be rolling out its tests, but it hopes to get FDA approval this summer. He said the company is already starting to work with businesses to help advise them as they determine how to safely get employees back to work. Many are concerned about a potential second shutdown if there's another outbreak in their area.

He believes that testing and contact tracing, where government officials track down and warn people who might have been exposed to Covid-19, are key to reopening the economy.

"I'm also sensing that a lot of people don't have a ton of hope," Kelly said. "Now we have to really try. If we try, we can win."

More:

Ginkgo Bioworks CEO on scaling up Covid-19 testing: 'If we try, we can win' - CNBC

CRISPR And CRISPR-Associated (Cas) Genes Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast…

Los Angeles, United State: Complete study of the global CRISPR And CRISPR-Associated (Cas) Genes market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global CRISPR And CRISPR-Associated (Cas) Genes industry. Research techniques like PESTLE and Porters Five Forces analysis have been deployed by the researchers. They have also provided accurate data on CRISPR And CRISPR-Associated (Cas) Genes production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.

The research study includes great insights about critical market dynamics, including drivers, restraints, trends, and opportunities. It also includes various types of market analysis such as competitive analysis, manufacturing cost analysis, manufacturing process analysis, price analysis, and analysis of market influence factors. It is a complete study on the global CRISPR And CRISPR-Associated (Cas) Genes market that can be used as a set of effective guidelines for ensuring strong growth in the coming years. It caters to all types of interested parties, viz. stakeholders, market participants, investors, market researchers, and other individuals associated with the CRISPR And CRISPR-Associated (Cas) Genes business.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)https://www.qyresearch.com/sample-form/form/958288/global-crispr-and-crispr-associated-cas-genes-market

It is important for every market participant to be familiar with the competitive scenario in the global CRISPR And CRISPR-Associated (Cas) Genes industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key Players Mentioned in the Global CRISPR And CRISPR-Associated (Cas) Genes Market Research Report: , Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, GE Healthcare Dharmacon

Global CRISPR And CRISPR-Associated (Cas) Genes Market Segmentation by Product: Genome Editing, Genetic engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering

Global CRISPR And CRISPR-Associated (Cas) Genes Market Segmentation by Application: , Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes

The report has classified the global CRISPR And CRISPR-Associated (Cas) Genes industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the CRISPR And CRISPR-Associated (Cas) Genes manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall CRISPR And CRISPR-Associated (Cas) Genes industry.

Additionally, the industry analysts have studied key regions including North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, along with their respective countries. Here, they have given a clear-cut understanding of the present and future situations of the global CRISPR And CRISPR-Associated (Cas) Genes industry in key regions. This will help the key players to focus on the lucrative regional markets.

Key questions answered in the report:

Request for customization in Report:https://www.qyresearch.com/customize-request/form/958288/global-crispr-and-crispr-associated-cas-genes-market

Table of Content

Table of Contents Executive Summary 1 CRISPR And CRISPR-Associated (Cas) Genes Market Overview1.1 Product Overview and Scope of CRISPR And CRISPR-Associated (Cas) Genes1.2 CRISPR And CRISPR-Associated (Cas) Genes Segment by Type1.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Production Growth Rate Comparison by Type (2014-2025)1.2.2 Genome Editing1.2.3 Genetic engineering1.2.4 gRNA Database/Gene Librar1.2.5 CRISPR Plasmid1.2.6 Human Stem Cells1.2.7 Genetically Modified Organisms/Crops1.2.8 Cell Line Engineering1.3 CRISPR And CRISPR-Associated (Cas) Genes Segment by Application1.3.1 CRISPR And CRISPR-Associated (Cas) Genes Consumption Comparison by Application (2014-2025)1.3.2 Biotechnology Companies1.3.3 Pharmaceutical Companies1.3.4 Academic Institutes1.3.5 Research and Development Institutes1.3 Global CRISPR And CRISPR-Associated (Cas) Genes Market by Region1.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Region1.3.2 North America Status and Prospect (2014-2025)1.3.3 Europe Status and Prospect (2014-2025)1.3.4 China Status and Prospect (2014-2025)1.3.5 Japan Status and Prospect (2014-2025)1.3.6 Southeast Asia Status and Prospect (2014-2025)1.3.7 India Status and Prospect (2014-2025)1.4 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size1.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (2014-2025)1.4.2 Global CRISPR And CRISPR-Associated (Cas) Genes Production (2014-2025) 2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Competition by Manufacturers2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Production Market Share by Manufacturers (2014-2019)2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Share by Manufacturers (2014-2019)2.3 Global CRISPR And CRISPR-Associated (Cas) Genes Average Price by Manufacturers (2014-2019)2.4 Manufacturers CRISPR And CRISPR-Associated (Cas) Genes Production Sites, Area Served, Product Types2.5 CRISPR And CRISPR-Associated (Cas) Genes Market Competitive Situation and Trends2.5.1 CRISPR And CRISPR-Associated (Cas) Genes Market Concentration Rate2.5.2 CRISPR And CRISPR-Associated (Cas) Genes Market Share of Top 3 and Top 5 Manufacturers2.5.3 Mergers & Acquisitions, Expansion 3 Global CRISPR And CRISPR-Associated (Cas) Genes Production Market Share by Regions3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Production Market Share by Regions3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Regions (2014-2019)3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)3.4 North America CRISPR And CRISPR-Associated (Cas) Genes Production3.4.1 North America CRISPR And CRISPR-Associated (Cas) Genes Production Growth Rate (2014-2019)3.4.2 North America CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)3.5 Europe CRISPR And CRISPR-Associated (Cas) Genes Production3.5.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Production Growth Rate (2014-2019)3.5.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)3.6 China CRISPR And CRISPR-Associated (Cas) Genes Production (2014-2019)3.6.1 China CRISPR And CRISPR-Associated (Cas) Genes Production Growth Rate (2014-2019)3.6.2 China CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)3.7 Japan CRISPR And CRISPR-Associated (Cas) Genes Production (2014-2019)3.7.1 Japan CRISPR And CRISPR-Associated (Cas) Genes Production Growth Rate (2014-2019)3.7.2 Japan CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019) 4 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions4.2 North America CRISPR And CRISPR-Associated (Cas) Genes Consumption (2014-2019)4.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption (2014-2019)4.4 China CRISPR And CRISPR-Associated (Cas) Genes Consumption (2014-2019)4.5 Japan CRISPR And CRISPR-Associated (Cas) Genes Consumption (2014-2019) 5 Global CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price Trend by Type5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Production Market Share by Type (2014-2019)5.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2014-2019)5.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price by Type (2014-2019)5.4 Global CRISPR And CRISPR-Associated (Cas) Genes Production Growth by Type (2014-2019) 6 Global CRISPR And CRISPR-Associated (Cas) Genes Market Analysis by Applications6.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2014-2019)6.2 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth Rate by Application (2014-2019) 7 Company Profiles and Key Figures in CRISPR And CRISPR-Associated (Cas) Genes Business7.1 Caribou Biosciences7.1.1 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.1.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.1.4 Main Business and Markets Served7.2 Addgene7.2.1 Addgene CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.2.4 Main Business and Markets Served7.3 CRISPR THERAPEUTICS7.3.1 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.3.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.3.4 Main Business and Markets Served7.4 Merck KGaA7.4.1 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.4.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.4.4 Main Business and Markets Served7.5 Mirus Bio LLC7.5.1 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.5.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.5.4 Main Business and Markets Served7.6 Editas Medicine7.6.1 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.6.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.6.4 Main Business and Markets Served7.7 Takara Bio USA7.7.1 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.7.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.7.4 Main Business and Markets Served7.8 Thermo Fisher Scientific7.8.1 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.8.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.8.4 Main Business and Markets Served7.9 Horizon Discovery Group7.9.1 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.9.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.9.4 Main Business and Markets Served7.10 Intellia Therapeutics7.10.1 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Production Sites and Area Served7.10.2 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction, Application and Specification7.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue, Price and Gross Margin (2014-2019)7.10.4 Main Business and Markets Served7.11 GE Healthcare Dharmacon 8 CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Cost Analysis8.1 CRISPR And CRISPR-Associated (Cas) Genes Key Raw Materials Analysis8.1.1 Key Raw Materials8.1.2 Price Trend of Key Raw Materials8.1.3 Key Suppliers of Raw Materials8.2 Proportion of Manufacturing Cost Structure8.3 Manufacturing Process Analysis of CRISPR And CRISPR-Associated (Cas) Genes8.4 CRISPR And CRISPR-Associated (Cas) Genes Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers9.1 Marketing Channel9.1.1 Direct Marketing9.1.2 Indirect Marketing9.2 CRISPR And CRISPR-Associated (Cas) Genes Distributors List9.3 CRISPR And CRISPR-Associated (Cas) Genes Customers 10 Market Dynamics10.1 Market Trends10.2 Opportunities10.3 Market Drivers10.4 Challenges10.5 Influence Factors 11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Forecast11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast11.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Production Growth Rate Forecast (2019-2025)11.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate Forecast (2019-2025)11.1.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price and Trend Forecast (2019-2025)11.2 Global CRISPR And CRISPR-Associated (Cas) Genes Production Forecast by Regions (2019-2025)11.2.1 North America CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2019-2025)11.2.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2019-2025)11.2.3 China CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2019-2025)11.2.4 Japan CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2019-2025)11.3 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast by Regions (2019-2025)11.3.1 North America CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast (2019-2025)11.3.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast (2019-2025)11.3.3 China CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast (2019-2025)11.3.4 Japan CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast (2019-2025)11.4 Global CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue and Price Forecast by Type (2019-2025)11.5 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast by Application (2019-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source13.1 Methodology/Research Approach13.1.1 Research Programs/Design13.1.2 Market Size Estimation13.1.3 Market Breakdown and Data Triangulation13.2 Data Source13.2.1 Secondary Sources13.2.2 Primary Sources13.3 Author List13.4 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

Visit link:

CRISPR And CRISPR-Associated (Cas) Genes Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast...